Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer

9 Jan 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Viral Infections and Immunology Research
Share to Virus-based gene therapy research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31972133
DOI: 10.1016/j.ymthe.2019.12.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene TransferPMID 31972133Read ↗

Understanding AAV vector immunogenicity: from particle to patientSemantic proximity Read ↗

AAV vectors: The Rubik’s cube of human gene therapySemantic proximity Read ↗

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene TransferSemantic proximity Read ↗

Human Immune Responses to Adeno-Associated Virus (AAV) VectorsSemantic proximity Read ↗

Unraveling the Complex Story of Immune Responses to AAV Vectors Trial After TrialSemantic proximity Read ↗

AAV vectors: is clinical success on the horizon?Semantic proximity Read ↗

AAV vector development, back to the futureSemantic proximity Read ↗

The clinical landscape for AAV gene therapiesSemantic proximity Read ↗

Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapySemantic proximity Read ↗

Emerging Immunogenicity and Genotoxicity Considerations of Adeno-Associated Virus Vector Gene Therapy for HemophiliaSemantic proximity Read ↗

AAV vector manufacturing process design and scalability - Bending the trajectory to address vector-associated immunotoxicitiesSemantic proximity Read ↗

AAVrh.10 immunogenicity in mice and humans. Relevance of antibody cross-reactivity in human gene therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.